Vision impairment therapies
Nat Rev Drug Discov
.
2003 Jun;2(6):425-6.
doi: 10.1038/nrd1113.
Authors
Ronald C Renaud
1
,
Hayley Xuereb
Affiliation
1
Bear Stearns & Co, Inc, New York, New York, USA. rrenaud@bear.com
PMID:
12790152
DOI:
10.1038/nrd1113
No abstract available
MeSH terms
Clinical Trials as Topic / methods
Clinical Trials as Topic / trends
Humans
Technology, Pharmaceutical / methods*
Technology, Pharmaceutical / trends
Vision Disorders / drug therapy*
Vision Disorders / surgery